Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-28 Sale | 2026-09-02 6:12 pm | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 290 | $0 | $0 | 16,572,966 (Indirect Direct) | View |
| 2026-06-18 Sale | 2026-06-23 6:40 pm | CDT Equity Inc. | CDT | Taylor Mark Andrew Prospect Capital Securities Ltd Prospect Finance Ltd 10% Owner | 2,068,000 | $1.4244 | $2,945,586 | 0 (Indirect) | View |
| 2024-10-03 Sale | 2024-10-07 7:38 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 3,808,000 | $0.10332 | $393,439 | 6,092,000 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 5:02 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 2,600,000 | $0.11448 | $297,644 | 9,900,000 (Direct) | View |
| 2024-07-03 Sale | 2024-09-19 5:01 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 15,301,068 | $0.30014 | $4,592,487 | 2,444,277 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-30 Other | 2026-09-02 6:12 pm | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 5,436,830 | $0.0001 | 16,572,966 (Indirect) | View |
| 2026-08-28 Other | 2026-09-02 6:12 pm | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 5,436,830 | $0 | 16,572,966 (Indirect) | View |
| 2026-08-28 Exercise | 2026-09-02 6:12 pm | 2026-08-28 N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 5,436,830 | $0.0001 | 16,572,966 (Indirect) | View |
| 2026-03-24 Option Award | 2026-05-14 08:42 am | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 147,401 | $0 | 262,766 (Indirect) | View |
| 2026-05-13 Option Award | 2026-05-14 08:42 am | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 100,000 | $1.9 | 262,766 (Indirect) | View |
| 2026-03-24 Conversion | 2026-05-14 08:42 am | 2025-12-08 N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer | 147,401 | $0.0001 | 262,766 (Indirect) | View |
Ownership | 2026-04-30 8:16 pm | N/A N/A | CDT Equity Inc. | CDT | Olsen Ulrik K Director | 0 | $0 | 233,585 (Direct) | View |
| 2026-02-19 Other | 2026-03-30 9:23 pm | 2026-03-17 N/A | CDT Equity Inc. | CDT | Taylor Mark Andrew Prospect Capital Securities Ltd Prospect Finance Ltd 10% Owner | 112,597,509 | $0 | 117,776,775 (Indirect) | View |
Ownership | 2026-03-30 9:22 pm | N/A N/A | CDT Equity Inc. | CDT | Taylor Mark Andrew Prospect Capital Securities Ltd Prospect Finance Ltd 10% Owner | 0 | $0 | 325,958 (Indirect) | View |
| 2026-02-19 Option Award | 2026-02-23 8:27 pm | N/A N/A | CDT Equity Inc. | CDT | Farley Chele Chiavacci Director | 1,951,357 | $1.04 | 1,957,961 (Direct) | View |
| 2025-12-08 Option Award | 2025-12-22 4:05 pm | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Corvus Capital Ltd. Chief Executive Officer 10% Owner | 224,800 | $1.79 | 4,072,487 (Indirect) | View |
| 2025-12-08 Option Award | 2025-12-22 4:05 pm | 2025-12-08 N/A | CDT Equity Inc. | CDT | Regan Andrew Corvus Capital Ltd. Chief Executive Officer 10% Owner | 3,685,815 | $0.0001 | 4,072,487 (Indirect) | View |
| 2025-09-19 Option Award | 2025-09-22 4:29 pm | N/A N/A | CDT Equity Inc. | CDT | Regan Andrew Chief Executive Officer 10% Owner | 1,120,000 | $0.6863 | 1,294,993 (Direct) | View |
| 2025-09-19 Option Award | 2025-09-19 4:46 pm | N/A N/A | CDT Equity Inc. | CDT | Bligh James CFO | 480,000 | $0 | 480,024 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-26 4:30 pm | N/A 2035-08-05 | CDT Equity Inc. | CDT | Fry Simon Jeremy Director | 50,000 | $0 | 51,956 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-26 4:30 pm | N/A 2035-08-05 | CDT Equity Inc. | CDT | Lewis-Hall Freda C Director | 50,000 | $0 | 55,145 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-26 4:30 pm | N/A 2035-08-05 | CDT Equity Inc. | CDT | Farley Chele Chiavacci Director | 50,000 | $0 | 52,369 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-13 07:17 am | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Chief Executive Officer 10% Owner | 154,799 | $3.23 | 174,993 (Indirect) | View |
Ownership | 2025-05-07 5:35 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Sarborg Ltd 10% Owner | 0 | $0 | 1,853,933 (Direct) | View |
| 2025-04-16 Option Award | 2025-04-17 4:05 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 115,194 | $0.8681 | 165,238 (Direct) | View |
| 2025-03-30 Option Award | 2025-04-01 9:13 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director | 47,612 | $0.89 | 77,193 (Direct) | View |
| 2025-03-30 Option Award | 2025-04-01 9:09 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director | 29,354 | $0.89 | 31,354 (Direct) | View |
| 2025-03-30 Option Award | 2025-04-01 9:07 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 32,022 | $0.89 | 35,537 (Direct) | View |
| 2025-03-30 Option Award | 2025-04-01 9:04 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 46,629 | $0.89 | 50,044 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 5:06 pm | N/A 2034-12-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 420,000 | $0.071 | 420,000 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 5:06 pm | N/A 2034-12-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 420,000 | $0.071 | 420,000 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 5:06 pm | N/A 2034-12-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director | 420,000 | $0.071 | 420,000 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 5:06 pm | N/A 2034-12-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director | 420,000 | $0.071 | 420,000 (Direct) | View |
Ownership | 2024-12-20 5:05 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director | 0 | $0 | 200,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director | 437,976 | $0.0919 | 2,958,287 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A 2034-11-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer | 840,000 | $0.0919 | 840,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 299,238 | $0.0919 | 351,510 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A 2034-11-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO | 1,890,000 | $0.0919 | 1,890,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 75,000 | $0 | 341,594 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 266,594 | $0.0919 | 341,594 (Direct) | View |
| 2024-06-14 Other | 2024-09-19 5:01 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 1,100,000 | $0 | 2,444,277 (Indirect) | View |
Ownership | 2024-08-13 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 0 | $0 | 14,500,000 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-11 5:56 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 37,272 | $0 | 52,272 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-11 5:53 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO | 37,272 | $0 | 37,272 (Direct) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | 2025-04-22 2027-04-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer | 400,664 | $0 | 600,996 (Direct) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | 2025-04-22 2027-04-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Intelmed LLC Director | 504,061 | $0 | 504,061 (Indirect) | View |